Natco Pharma Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹735.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.53 per cent from ₹739.10 crore. This corresponds to a year-on-year *(YoY) decline of 44.68 per cent.
Operating Profit
Operating Profit stands at ₹186.50 crore, reflecting a quarter-on-quarter *(QoQ) increase of 46.16 per cent from ₹127.60 crore. This corresponds to a year-on-year *(YoY) decline of 67.34 per cent.
PBDT
PBDT stands at ₹317.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 37.71 per cent from ₹230.20 crore. This corresponds to a year-on-year *(YoY) decline of 49.64 per cent.
Profit Before Tax
Profit Before Tax stands at ₹269.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 50.11 per cent from ₹179.80 crore. This corresponds to a year-on-year *(YoY) decline of 52.81 per cent.
Net Profit
Net Profit stands at ₹206.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 23.23 per cent from ₹269.00 crore. This represents a 57.01 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Natco Pharma Ltd News
Natco Pharma Ltd Earnings
- YOY
- QOQ
Natco Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Natco Pharma Ltd Research Reports
Natco Pharma Ltd Financial Reports
Natco Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Natco Pharma | -0.43% | 2.99% | -2.61% | -8.48% | -14.04% | 2.45% |
| Astrazeneca Phar | -0.83% | -1.78% | -8.53% | -18.74% | -17.63% | -25.79% |
| Concord Biotech | -1.97% | -8.40% | -6.14% | 14.72% | 42.79% | -7.41% |
| Marksans Pharma | -1.41% | -1.72% | 0.42% | 26.25% | 104.15% | 102.28% |
| Corona Remedies | -0.10% | -4.49% | 0.41% | 7.37% | 33.84% | 47.15% |
| Akums Drugs | -0.98% | -1.13% | 6.02% | 30.07% | 71.00% | 81.92% |
| Strides Pharma | -1.43% | -4.20% | 20.54% | 7.46% | 26.14% | 44.87% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : V C Nannapaneni
Vice Chairman & Chief Executive Officer : Rajeev Nannapaneni
ED / EVP : PSRK Prasad
ED / President : D Linga Rao
Independent Non Exe. Director : A D Murthy Chavali
Independent Non Exe. Director : Vijayabhaskar Dronadula
Independent Non Exe. Director : B. Lakshminarayana
Independent Non Exe. Director : Kantipudi Suma
Independent Non Exe. Director : Nitin Jain
Company Sec. & Compli. Officer : Chekuri Venkat Ramesh